The upregulated expression and activity of ACLY have been reported in lung, prostate, bladder, breast, liver, colon, and gastric cancer, whereas the inhibition of ACLY suppresses the proliferation of tumor cells [48, 102–105]. This evidence concerns the gene ACLY and neoplasm.